total operating revenue up 257pc, page-2

BrainZ loses $NZ5m for year; revenue surges
10:19, Wednesday, 25 October 2006

Sydney - Wednesday - Oct 25: (RWE Australian Business News) -
New Zealand-based medical technology company BrainZ Instruments Ltd (ASX
code: BZI) incurred a net loss of $NZ4.96 million in the year ended
August 31, compared with a $NZ1.5 million loss for the previous year.
Total operating revenue rose 257 per cent to $4.66 million, of
which $1.6 million resulted from product sales of BRM2 monitors,
disposable sensors and associated products with the remainder comprising
interest revenue, government funding and foreign exchange gains.
The company incurred a non-recurring writedown of capitalised
development costs of $5.25 million.
The results presented are consistent with the company's
expectations set out in the prospectus of November 2005.
As a result of parent company Tru-Test Ltd applying to change
its balance date to March 31, BrainZ also intends to change its balance
date to March 31 with effect from March 31 2007.

*****

The total installed base of BrainZ monitors around the world
increased 79 per cent over the course of the 2006 financial year.
During this period, BrainZ sold 74 BRM2 brain monitors, a 100
per cent increase compared with the previous year.
In the last six months of the year BrainZ sold 49 BRM2 monitors,
up 96 per cent over the first six months and a 133 per cent increase
over the previous corresponding period.
BRM2 monitors are now used in 16 countries.